Biohaven Pharmaceutical Holding Co Ltd

Pfizer's purchase of migraine medication maker Biohaven Pharmaceutical represents a commitment to expand the reach of its calcitonin gene-related peptide (CGRP) franchise, CEO Vlad Coric told CNBC's Jim Cramer on Tuesday."There are still over 300,000 physicians in the U.S who write for the older triptans and have not yet written for one oral CGRP," Coric said in an interview on "Mad Money," referring to a class of medicine used to treat migraines."That's not acceptable — we have to bring the modern day, novel therapies to…

Here are the most important news, trends and analysis that investors need to start their trading day:1. Wall Street set to rise after S&P 500 hits lowest level in over a yearTraders work on the floor of the New York Stock Exchange (NYSE) in New York City, March 22, 2022.Brendan McDermid | ReutersU.S. stock futures bounced Tuesday, with investors hoping Wall Street can break its three-session losing streak. The S&P 500 on Monday fell to its lowest level in more than a year. The broad market index dropped 3.2%,…

A Peloton Interactive Inc. logo on a stationary bike at the company's showroom in Dedham, Massachusetts, U.S., on Wednesday, Feb. 3, 2021.Adam Glanzman | Bloomberg | Getty ImagesCheck out the companies making headlines in midday trading.Peloton – Shares tumbled 12% after the equipment maker disclosed it's piling up excess inventory and burning through cash in a disappointing earnings report. Peloton also issued a dim fiscal fourth-quarter sales outlook and expects an upcoming price hike may lose the company some…